Volitionrx Ltd SEC filings VNRX

Volitionrx Ltd has 1,004 filings in SEC EDGAR's recent list, going back to Aug 27, 2013. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (material agreement, other events). The company's fiscal year ends on December 31.

Volitionrx Ltd SEC filings
Form Description Filed Period
8-K Current report
Material agreement, Other events
Oct 27, 2026 Oct 23, 2026
4 Insider transaction Oct 23, 2026 Oct 21, 2026
4 Insider transaction Sep 30, 2026 Sep 28, 2026
4 Insider transaction Sep 30, 2026 Sep 28, 2026
8-K Current report
Unregistered share sale
Sep 25, 2026 Sep 22, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 16, 2026 —
8-K Current report
Unregistered share sale
Sep 15, 2026 Sep 9, 2026
8-K Current report
Other events
Sep 14, 2026 Sep 11, 2026
EFFECT Filing Sep 9, 2026 —
S-3/A Form s-3/a Sep 9, 2026 —
S-3/A Form s-3/a Sep 8, 2026 —
SCHEDULE 13D Ownership over 5% (active) Sep 4, 2026 —
8-K Current report
Material agreement
Sep 2, 2026 Sep 2, 2026
8-K Current report
Unregistered share sale
Sep 2, 2026 Aug 27, 2026
S-3 Shelf registration Aug 28, 2026 —
8-K Current report
Unregistered share sale
Aug 24, 2026 Aug 19, 2026
S-8 Employee stock plan registration Aug 21, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
8-K Current report
Unregistered share sale
Aug 7, 2026 Aug 6, 2026
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jul 21, 2026 Jul 17, 2026
EFFECT Filing Jul 17, 2026 —
S-3 Shelf registration Jul 10, 2026 —
8-K Current report
Unregistered share sale
Jun 18, 2026 Jun 17, 2026
8-K Current report
Material agreement, Other events
Jun 10, 2026 Jun 7, 2026
424B5 Prospectus supplement Jun 9, 2026 —
424B5 Prospectus supplement Jun 5, 2026 —
DEF 14A Proxy statement Jun 2, 2026 Jul 17, 2026
8-K Current report
Material agreement
May 22, 2026 May 21, 2026
8-K Current report
Officer or director change
May 15, 2026 May 12, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
PRE 14A Preliminary proxy statement May 13, 2026 May 12, 2026
10-K/A Amended annual report Apr 30, 2026 Dec 31, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Apr 28, 2026 Apr 28, 2026
8-K Current report
Listing notice, Other events
Apr 23, 2026 Apr 23, 2026
8-K Current report
Other events
Apr 17, 2026 Apr 17, 2026
8-K Current report
Shareholder vote results
Apr 1, 2026 Mar 31, 2026
10-K Annual report Mar 31, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 31, 2026 Mar 31, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Mar 3, 2026 Mar 1, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
8-K Current report
Unregistered share sale
Feb 20, 2026 Feb 17, 2026
EFFECT Filing Feb 19, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
CORRESP Letter to the SEC Feb 17, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 17, 2026 —
UPLOAD Letter from the SEC Feb 13, 2026 —
DEF 14A Proxy statement Feb 11, 2026 Feb 10, 2026
8-K Current report
Listing notice, Other events
Feb 9, 2026 Feb 6, 2026
S-3 Shelf registration Feb 9, 2026 —
4 Insider transaction Feb 3, 2026 Feb 1, 2026
4 Insider transaction Feb 3, 2026 Feb 1, 2026
4 Insider transaction Feb 3, 2026 Feb 1, 2026
D/A Filing Jan 28, 2026 —
PRE 14A Preliminary proxy statement Jan 26, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
4 Insider transaction Jan 23, 2026 Jan 22, 2026
8-K Current report
Material agreement, Unregistered share sale
Jan 8, 2026 Jan 7, 2026
8-K Current report
Officer or director change
Dec 11, 2025 Dec 5, 2025
4 Insider transaction Nov 17, 2025 Nov 17, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
8-K/A Amended current report
Material agreement
Nov 13, 2025 Nov 7, 2025
8-K/A Amended current report
Material agreement
Nov 10, 2025 Nov 7, 2025
8-K Current report
Material agreement
Nov 7, 2025 Nov 7, 2025
4 Insider transaction Nov 4, 2025 Nov 1, 2025
4 Insider transaction Nov 4, 2025 Nov 1, 2025
4 Insider transaction Nov 4, 2025 Nov 1, 2025
4 Insider transaction Nov 4, 2025 Nov 1, 2025
4 Insider transaction Nov 4, 2025 Nov 1, 2025
4 Insider transaction Oct 15, 2025 Oct 14, 2025
4 Insider transaction Oct 15, 2025 Oct 14, 2025
4 Insider transaction Oct 15, 2025 Oct 14, 2025
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure
Oct 14, 2025 Oct 10, 2025
424B5 Prospectus supplement Oct 14, 2025 —
424B5 Prospectus supplement Oct 9, 2025 —
4 Insider transaction Oct 7, 2025 Oct 4, 2025
4 Insider transaction Oct 7, 2025 Oct 4, 2025
4 Insider transaction Oct 7, 2025 Oct 4, 2025
4 Insider transaction Oct 7, 2025 Oct 4, 2025
4 Insider transaction Oct 7, 2025 Oct 4, 2025
4 Insider transaction Oct 7, 2025 Oct 4, 2025
4 Insider transaction Oct 7, 2025 Oct 4, 2025
4 Insider transaction Sep 30, 2025 Sep 28, 2025
4 Insider transaction Sep 30, 2025 Sep 28, 2025
4 Insider transaction Sep 30, 2025 Sep 28, 2025
4 Insider transaction Sep 30, 2025 Sep 28, 2025
4 Insider transaction Sep 30, 2025 Sep 28, 2025
4 Insider transaction Sep 30, 2025 Sep 28, 2025
4 Insider transaction Sep 15, 2025 Sep 12, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
4 Insider transaction Aug 19, 2025 Aug 15, 2025
10-Q/A Amended quarterly report Aug 15, 2025 Jun 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
424B5 Prospectus supplement Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Aug 6, 2025 Aug 5, 2025
4 Insider transaction Aug 6, 2025 Aug 5, 2025
4 Insider transaction Aug 5, 2025 Aug 1, 2025
4 Insider transaction Aug 5, 2025 Aug 1, 2025
4 Insider transaction Aug 5, 2025 Aug 1, 2025
4 Insider transaction Aug 5, 2025 Aug 1, 2025
4 Insider transaction Aug 5, 2025 Aug 1, 2025
4 Insider transaction Aug 5, 2025 Aug 1, 2025
8-K Current report
Material agreement, Other events
Aug 4, 2025 Aug 1, 2025
424B5 Prospectus supplement Aug 4, 2025 —
4 Insider transaction Jul 25, 2025 Jul 24, 2025
4 Insider transaction Jul 25, 2025 Jul 24, 2025
EFFECT Filing Jul 14, 2025 —
CORRESP Letter to the SEC Jul 10, 2025 —
UPLOAD Letter from the SEC Jul 10, 2025 —
S-3 Shelf registration Jul 3, 2025 —
4 Insider transaction Jul 3, 2025 Jul 1, 2025
4 Insider transaction Jul 3, 2025 Jul 1, 2025
4 Insider transaction Jul 3, 2025 Jul 1, 2025
4 Insider transaction Jul 3, 2025 Jul 1, 2025
4 Insider transaction Jul 3, 2025 Jul 1, 2025
4 Insider transaction Jul 3, 2025 Jul 1, 2025
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jun 20, 2025 Jun 18, 2025
4 Insider transaction Jun 16, 2025 Jun 12, 2025
4 Insider transaction Jun 4, 2025 Jun 3, 2025
4 Insider transaction Jun 3, 2025 Jun 1, 2025
4 Insider transaction Jun 3, 2025 Jun 1, 2025
4 Insider transaction Jun 3, 2025 Jun 1, 2025
4 Insider transaction Jun 3, 2025 Jun 1, 2025
4 Insider transaction Jun 3, 2025 Jun 1, 2025
4 Insider transaction Jun 3, 2025 Jun 1, 2025
4 Insider transaction Jun 3, 2025 Jun 1, 2025
4 Insider transaction Jun 3, 2025 Jun 1, 2025
4 Insider transaction Jun 3, 2025 Jun 1, 2025
4 Insider transaction Jun 3, 2025 Jun 1, 2025
4 Insider transaction Jun 3, 2025 Jun 1, 2025
4 Insider transaction Jun 3, 2025 Jun 1, 2025
D Filing May 30, 2025 —
4 Insider transaction May 19, 2025 May 19, 2025
4 Insider transaction May 19, 2025 May 19, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
DEF 14A Proxy statement Apr 29, 2025 Apr 24, 2025
RW WD Filing Apr 25, 2025 —
8-K Current report
Material agreement, Agreement ended
Apr 22, 2025 Apr 22, 2025
424B5 Prospectus supplement Apr 22, 2025 —
EFFECT Filing Apr 18, 2025 —
CORRESP Letter to the SEC Apr 16, 2025 —
RW Filing Apr 16, 2025 —
EFFECT Filing Apr 15, 2025 —
S-3/A Form s-3/a Apr 11, 2025 —
CORRESP Letter to the SEC Apr 11, 2025 —
UPLOAD Letter from the SEC Apr 10, 2025 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
In Vitro & In Vivo Diagnostic Substances (SIC 2835)
Listed as
VNRX (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Henderson, NV
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
93314
Former names
VOLITIONRX LTD (until Oct 27, 2026); STANDARD CAPITAL CORP (until Sep 29, 2011)

Other In Vitro & In Vivo Diagnostic Substances companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.